Matthew R. Redinbo
- Molecular Biology top 0.5%
- Oncology top 1%
- Pharmacology top 0.05%
- Genetics top 0.5%
- Pharmacology top 0.5%
- Co-authors
- Wim G. J. HolJames J. ChampouxLance StewartPhilip M. PotterSridhar ManiSteven A. KliewerAadra P. BhattBret D. Wallace
- Topics
- Gut microbiota and health (35 papers)Pharmacogenetics and Drug Metabolism (34 papers)Cancer therapeutics and mechanisms (23 papers)
- Journals
- ScienceProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Matthew R. Redinbo
164 papers receiving 12.9k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Biology 8.1k
- Oncology 2.6k
- Pharmacology 2.6k
- Genetics 2.0k
- Pharmacology 1.3k
Countries citing papers authored by Matthew R. Redinbo
This map shows the geographic impact of Matthew R. Redinbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Redinbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Redinbo more than expected).
Fields of papers citing papers by Matthew R. Redinbo
This network shows the impact of papers produced by Matthew R. Redinbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Redinbo. The network helps show where Matthew R. Redinbo may publish in the future.
Co-authorship network of co-authors of Matthew R. Redinbo
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Redinbo. A scholar is included among the top collaborators of Matthew R. Redinbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Redinbo. Matthew R. Redinbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 2 | |
| 7 | Plant “helper” immune receptors are Ca 2+ -permeable nonselective cation channelsbreakdown → | 258 |
| 8 | 150 | |
| 9 | Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogensbreakdown → | 239 |
| 10 | 59 | |
| 11 | 22 | |
| 12 | 24 | |
| 13 | 46 | |
| 14 | 21 | |
| 15 | Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzymebreakdown → | 811 |
| 16 | 328 | |
| 17 | Modulating transcriptional control of drug metabolism: A novel paradigm in drug therapeutics | 1 |
| 18 | 122 | |
| 19 | STRUCTURAL IMPACT OF THE LEUKEMIA DRUG 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) ON THE COVALENT HUMAN TOPOISOMERASE I-DNA COMPLEX | 1 |
| 20 | 32 |
About Matthew R. Redinbo
Matthew R. Redinbo is a scholar working on Pharmacology, Molecular Biology and Pharmacology, having authored 170 papers that have together received 13.1k indexed citations. Recurring topics across this work include Gut microbiota and health (35 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Cancer therapeutics and mechanisms (23 papers). The work is most often cited by research in Pharmacology (2.6k citations), Toxicology (669 citations) and Molecular Biology (8.1k citations). Matthew R. Redinbo has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Wim G. J. Hol, James J. Champoux, Lance Stewart, Philip M. Potter, Sridhar Mani, Steven A. Kliewer, Aadra P. Bhatt, Bret D. Wallace, Scott J. Bultman and Ryan E. Watkins. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.